MACROGENICS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 7762
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 64191
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 18149
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1683
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 11195
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1106
 
  
 
A61Q USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS 158
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0009,902 Methods for the Treatment of Disease Using Immunoglobulins Having Fc Regions with Altered Affinities for FcgammaRactivating and FcgammaRinhibitingJun 13, 17Jan 11, 18[A61K, C07K]
2017/0362,333 Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses ThereofJun 19, 17Dec 21, 17[A61K, G01N, C07K]
2017/0247,452 Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses ThereofSep 22, 15Aug 31, 17[C07K]
2017/0233,472 ROR1-Binding Molecules, and Methods of Use ThereofFeb 15, 17Aug 17, 17[C07K]
2017/0204,176 Tri-Specific Binding Molecules That Specifically Bind to Multiple Cancer Antigens and Methods of Use ThereofMay 29, 15Jul 20, 17[C07K]
2017/0198,045 Tri-Specific Binding Molecules and Methods of Use ThereofMay 29, 15Jul 13, 17[C07K]
2017/0157,251 Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses ThereofDec 05, 16Jun 08, 17[A61K, C07K]
2016/0289,333 Antibodies with Altered Binding to FcRn and Methods of Using SameApr 07, 16Oct 06, 16[A61K, C07K]
2016/0257,761 HER2/neu-Specific Antibodies and Methods of Using SameMar 04, 16Sep 08, 16[A61K, C07K]
2016/0017,038 Bispecific Molecules That are Immunoreactive with Immune Effector Cells That Express an Activating Receptor and an Antigen Expressed by a Cell Infected by a Virus and Uses ThereofMar 13, 14Jan 21, 16[C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9908938 Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereofMar 13, 14Mar 06, 18[A61K, C12N, C07K]
9896508 Antibodies reactive with B7-H3 and uses thereofMay 31, 16Feb 20, 18[A61K, G01N, C07K]
9889197 Covalently-associated diabody complexes that possess charged coil domains and that are capable of enhanced binding to serum albuminJul 29, 11Feb 13, 18[A61K, C07K]
9822181 Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereofAug 20, 14Nov 21, 17[A61K, C07K]
9737599 Combination of FcγRIIB-specific antibodies and CD20-specific antibodies and methods of use thereofJun 04, 14Aug 22, 17[A61K, G01N, C07K]
9714295 Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofJun 01, 15Jul 25, 17[A61K, G01N, C07K]
9714296 Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereofJun 01, 15Jul 25, 17[A61K, G01N, C07K]
9708408 English Title Not AvailableJan 16, 14Jul 18, 17[A61K, C07K]
9695236 BCR-complex-specific antibodies and methods of using sameFeb 24, 15Jul 04, 17[A61K, C07K]
9587021 CD3-binding molecules capable of binding to human and non-human CD3May 16, 12Mar 07, 17[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0333,111 Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-LifeAbandonedMay 24, 16Nov 17, 16[C07K]
8313916 KID31 and antibodies that bind theretoExpiredFeb 13, 10Nov 20, 12[C12P, G01N, C07K]
2012/0269,811 HUMANIZED FC GAMMA RIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOFAbandonedJun 18, 12Oct 25, 12[A61K, A61P, A61N, C07K]
2012/0263,711 Engineering Fc Antibody Regions to Confer Effector FunctionAbandonedMay 24, 12Oct 18, 12[A61K, A61P, C07K]
8216578 Antibodies to oncostatin M receptorExpiredJul 02, 09Jul 10, 12[A61K]
2012/0110,682 Animal Model for Toxicology and Dose PredictionAbandonedJan 11, 12May 03, 12[A61K]
2012/0070,429 HUMANIZED ANTIBODIES AGAINST WEST NILE VIRUS AND THERAPEUTIC AND PROPHYLACTIC USES THEREOFAbandonedAug 22, 11Mar 22, 12[A61K, A61P]
2012/0034,221 T-Cell Receptor Antibodies And Methods of Use ThereofAbandonedOct 14, 11Feb 09, 12[A61K, C12P, C12N, A61P, C07K]
2012/0009,186 FcGammaRIIB Specific Antibodies and Methods of Use ThereofAbandonedSep 21, 11Jan 12, 12[A61K, A61P, C07K]
2011/0152,504 CD16A Binding Proteins and Use for the Treatment of Immune DisordersAbandonedOct 14, 10Jun 23, 11[C07K]
2011/0136,689 Dual Expression Vector System for Antibody Expression in Bacterial and Mammalian CellsAbandonedJan 26, 11Jun 09, 11[C12N, C40B]
2011/0081,347 Antibodies with Altered Binding to FcRn and Methods of Using SameAbandonedJun 04, 09Apr 07, 11[A61K, C07H, A61P, C07K]
2011/0045,006 LUCA2 and Antibodies That Bind TheretoAbandonedOct 29, 10Feb 24, 11[A61K, A61P]
7847070 LUCA2 and antibodies that bind theretoExpiredJan 31, 06Dec 07, 10[C12P, C07K]
2010/0196,372 FcgammaRIIB Fusion Proteins and Compositions ThereofAbandonedMar 11, 10Aug 05, 10[A61K, A61P]
7687242 KID31 and antibodies that bind theretoExpiredJan 12, 06Mar 30, 10[C12P, G01N, C07K]
2010/0015,142 METHODS FOR THE TREATMENT OF LADA AND OTHER ADULT- ONSET AUTOIMMUNE USING IMMUNOSUPPRESSIVE MONOCLONAL ANTIBODIES WITH REDUCED TOXICITYAbandonedDec 13, 07Jan 21, 10[A61K, A61P]
2009/0324,593 Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereofAbandonedJun 11, 09Dec 31, 09[A61K, C12Q, A61P, C07K]
7572456 Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereofExpiredSep 13, 05Aug 11, 09[A61K, C12P, C12N, A61Q]
7572896 Antibodies to oncostatin M receptorExpiredFeb 03, 06Aug 11, 09[C12N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.